Growth kinetics of multiple Acinetobacter baumannii resistotype after meropenem-based antibiotic combination exposure.
Sign Up to like & getrecommendations! Published in 2022 at "F1000Research"
DOI: 10.12688/f1000research.122221.2
Abstract: Background: Carbapenems are the treatment of choice for multidrug-resistant (MDR) and extensively drug-resistant (XDR) Acinetobacter baumannii infections, but the emergence of carbapenem-resistant A. baumannii (CRAB) has rendered it ineffective in the vast majority of cases. Combination therapy… read more here.
Keywords: growth; combination; ampicillin sulbactam; meropenem ampicillin ... See more keywords